A Comparative Study of Dextran-40 versus Crystalloid Infusion in Nonhemorrhagic, Nonhypovolemic Shock in Emergency Medicine

Abstract

Background: Shock is a condition of inadequate tissue perfusion due to an imbalance between oxygen demand and supply, classified into hypovolemic, cardiogenic, obstructive, and distributive types, each with distinct causes and treatment approaches. Crystalloids are the preferred intravenous fluids for resuscitation, while the safety and efficacy of synthetic colloids like dextran-40, as an alternative to albumin in non-hemorrhagic, non-hypovolemic shock, remain under investigation. This study explores the potential of dextran-40 in critical patients, aiming to provide clarity on its role compared to crystalloids.

Objectives: The study aims to evaluate the efficacy of dextran in achieving early hemodynamic stability, compare dextran infusion with crystalloid fluids in managing shock during the initial hours, and assess their outcomes in terms of multi-organ failure.

Methods: This prospective randomized controlled study evaluated the effects of Dextran-40 versus crystalloids in patients with non-hemorrhagic, non-hypovolemic shock presenting to the emergency department. Patients were assessed using qSOFA criteria, and initial resuscitation was performed with normal saline, followed by group-specific interventions. Outcomes were monitored through vital signs, ABG parameters, lactate clearance, and mental status, with statistical analysis performed using SPSS and R software.

Conclusion: The study found no significant advantage of dextran-40 over crystalloids for resuscitation in distributive shock, highlighting the need for larger, multicenter, randomized trials to validate its efficacy and safety. While promising early practices like goal-directed resuscitation and conservative fluid management show potential, further research is essential to establish dextran-40 as a reliable alternative to albumin in sepsis management.